Medicare evaluating coverage for $56,000 Alzheimer's drug
WASHINGTON (AP) - Medicare on Monday launched a formal process to decide whether to cover Aduhelm, the new Alzheimer's drug whose $56,000-a-year price tag and unproven benefits hav…
WASHINGTON (AP) - Medicare on Monday launched a formal process to decide whether to cover Aduhelm, the new Alzheimer's drug whose $56,000-a-year price tag and unproven benefits hav…